Generic Taxotere Lawsuits Allowed in MDL
The U.S. Judicial Panel on Multidistrict Litigation (JPML) allowed claims revolving around the generic form of Taxotere (docetaxel) to be included in the current Taxotere MDL being tried in the Eastern District of Louisiana. Currently, there are almost 800 lawsuits pending in the MDL. Current Litigation The lawsuits accuse Taxotere manufacturer, Sanofi-Aventis and other
Read More
Why Does Taxotere Cause Permanent Hair Loss?
Chemotherapy-induced hair loss (alopecia) is a side effect many breast cancer patients understand is a distinct possibility. However, they believe the alopecia only occurs during treatment. After chemotherapy and remission, survivors look forward to hair regrowth, a visible sign of recovery. Tragically, for many, they will never grow hair again after using chemotherapy drug, Taxotere.
Read More
Taxotere Manufacturer Hid Side Effect of Permanent Hair Loss
One in eight women will be diagnosed with breast cancer. This equates to almost 300,000 U.S. women every year. Almost 75% of these women will use Taxotere to battle their cancer. But, they were never told there is a chance that by using Taxotere, they could always look like a cancer patient. Taxotere, manufactured by
Read MoreMichael Brady Lynch Lecturers on Pradaxa, Xarelto and Eliquis Cases
Attorney Michel Brady Lynch, Esq. of The Michael Brady Lynch Firm in Winter Park spoke on March 11th in Ft. Lauderdale for Mass Torts Nexus on the subject Anticoagulant Uncontrollable Bleeding Litigation: Pradaxa, Xarelto and Eliquis. Mr. Lynch also spoke on March 16th in Orlando at the Ritz-Carlton Grande Lakes for HB Litigation Conferences: Mass
Read More
Viberzi Increases Pancreatitis Risk
After two patients without a gallbladder died while taking the irritable bowel syndrome drug, Viberzi, the FDA warns all users about an increased risk of serious pancreatitis while on the medication. An FDA review found patients, especially without a gallbladder, have an increased risk of developing serious pancreatitis that could result in hospitalization or death.
Read MoreAnnual Report Shows Growing Risperdal Cases
According to a recent annual report, there are close to 20,000 Risperdal lawsuits pending against manufacturers, Johnson & Johnson and its subsidiary Janssen Pharmaceuticals. The report stated that Johnson & Johnson along with Janssen is involved in many product liability claims and lawsuits involving Risperdal and other products. Risperdal is a powerful second-generation antipsychotic approved
Read More
Eliquis Becoming Most Popular Blood Thinner
For years, Johnson & Johnson’s anticoagulant, Xarelto was the market leader of blood thinners. Now, Eliquis, marketed by Bristol-Myers Squibb and Pfizer is leading Xarelto based upon prescription data. Eliquis brought in 667,000 prescriptions last September while Xarelto had 711,000. This isn’t a surprise since Bristol-Myers Squibb and Pfizer spent double the amount of Johnson
Read More
Xarelto Tested For New Use
The dangerous blood thinner, Xarelto headed for a new use. Manufacturer, Janssen announced they would be stopping their COMPASS trial a year early. This trial is part of their Explorer research program to expand Xarelto to 10 more label uses. COMPASS trial was evaluating the efficacy and safety of the blood thinner for the prevention
Read More
Why Are Blood Thinners so Dangerous?
If you are at risk for a stroke or heart attack, a doctor may prescribe a blood thinner such as Xarelto or Eliquis. These drugs are heralded as life-saving medications. But, they also bring a fatal side effect, too, and there is no way to reverse it. Why Would I Need a Blood Thinner? More than
Read More